You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BTAI Exercise Disclosure
Yocca Frank · SEC Form 4 · Filed Jun 17, 2026
Exercise
Reported value range
Not reported
Yocca Frank Chief Scientific Officer
BTAI
BioXcel Therapeutics
BTAI
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
BTAI daily price context
Close on/before transaction
$1.16
Jun 15, 2026
First close after public filing
$1.2
Jun 18, 2026
30-day return after filing
-26.05%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 35 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-075300
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bioxcel Therapeutics, Inc. BTAI Current | Exercise | Jun 15, 2026 | Not reported |
| Bioxcel Therapeutics, Inc. BTAI | Exercise | Jun 15, 2026 | $0 |